Literature DB >> 6297004

Rabies virus glycoprotein analogs: biosynthesis in Escherichia coli.

E Yelverton, S Norton, J F Obijeski, D V Goeddel.   

Abstract

The surface of rabies virus is composed of an approximately 60,000 dalton glycoprotein, in which most of the antigenic and immunogenic determinants of the virus reside. We have constructed plasmids for the direct expression in Escherichia coli of the mature full length rabies glycoprotein gene and also for the expression of a glycoprotein gene which has been truncated to exclude the coding region for a hydrophobic, possibly transmembrane, domain of the protein. Escherichia coli harboring the plasmids synthesize analog proteins which conform by several biochemical and antigenic criteria to rabies glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297004     DOI: 10.1126/science.6297004

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  33 in total

1.  Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus.

Authors:  Y H Chong; J M Ball; C J Issel; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  High level expression of a functionally active cholera toxin B: rabies glycoprotein fusion protein in tobacco seeds.

Authors:  Siddharth Tiwari; Devesh K Mishra; Sribash Roy; Ankit Singh; P K Singh; Rakesh Tuli
Journal:  Plant Cell Rep       Date:  2009-10-10       Impact factor: 4.570

3.  Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones.

Authors:  Y Gaudin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.

Authors:  R Ramya; B Mohana Subramanian; V Sivakumar; R L Senthilkumar; K R S Sambasiva Rao; V A Srinivasan
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

5.  An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro.

Authors:  P Coulon; J P Ternaux; A Flamand; C Tuffereau
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein.

Authors:  Y Gaudin; H Raux; A Flamand; R W Ruigrok
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein.

Authors:  I Seif; P Coulon; P E Rollin; A Flamand
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.

Authors:  J W Templeton; C Holmberg; T Garber; R M Sharp
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

9.  Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in E. coli.

Authors:  M A Boss; J H Kenten; C R Wood; J S Emtage
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

10.  Molecular characterization of a Chinese variant of the Flury-LEP strain.

Authors:  Linzhu Ren
Journal:  Virol J       Date:  2010-04-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.